Big Pharma — cardiovascular diseases

New insight into neovessel formation shows promise in future treatment of cardiovascular diseases A new study by researchers at the University of Eastern Finland provides novel insight into the previously unknown effects of factors regulating blood vessel formation. In the study, bone morphogenetic factor 6, i.e. BMP6, was shown – for the first time - to regulate blood vessel formation via vascular endothelial growth factor receptor 2 (VEGFR2) and Hippo signalling pathway. The findings can be used in developing treatments for cardiovascular diseases.  Cardiovascular diseases are the leading cause of death in the Western world. In many of these diseases, blood circulation is decreased due to narrowed blood vessels, leading to inadequate tissue perfusion and oxygen deprivation. The formation of new...